Using Secondary Data to Evaluate Sex-based Heterogeneity of GLP-1 Agonists and SGLT2 Inhibitors on Cardiovascular-Kidney-Metabolic Health (CKMH) Outcomes in Real-world Settings (DASH-CKMH)

NCT07188545 · clinicaltrials.gov ↗

ACTIVE_NOT_RECRUITING

Status

23280000

Enrollment

OTHER

Sponsor class

Conditions

Cardiovascular Kidney Metabolic Syndrome

Interventions

DRUG: Intervention
DRUG: Active Comparator

Sponsor

Ohio State University

Collaborators

[object Object]